Stocks › Drug Manufacturers - Specialty & Generic › PCRX

Pacira BioSciences PCRX

US equityMarket cap rank #3237Drug Manufacturers - Specialty & Generic

$25.20 +$0.44 (+1.78%)

Pre-market · Oct 8, 9:10 am ET · After hours $25.20 0.00%

Open$25.05

Prev close$24.76

Day range$24.99 – $26.00

Volume802.7K

Market cap$1.00B

P/E (TTM)72.0

Dividend yield–

Ownership & positioning

Who holds it, who is betting against it, and where the big money is moving

Institutional ownership114.1%-0.40 pts vs. prior quarter

Institutions holding305+0 vs. prior quarter

Insider trades (recent)23 buys / 27 sellsNet selling

Short interest18.97% of floatDays to cover 13.0 · as of 15 Sep 2026

Short-sale volume share25.2%5-day average of daily volume

Short-sale volume as % of daily volume

Large-order net flow, last 20 sessions

Net of large-order buying minus selling, in USD. Over this window: −$2.03M (7 inflow days, 13 outflow days).

Net flow by order size, last 20 sessions

Super/Big orders approximate institutional-size trades; Mid/Small approximate retail-size trades. Net buy minus sell value in each bucket, summed over the window.

The five largest holders on file together own 40.3% of shares outstanding.

Largest holders

BlackRock16.82%
DOMA Perpetual Capital Management, LLC6.97%
Vanguard Portfolio Management, LLC6.04%
Dimensional Fund Advisors5.28%
State Street Global Advisors5.17%
Vanguard Capital Management, LLC4.90%
D. E. Shaw & Co., L.P.4.89%
Renaissance Technologies Corp.4.35%

By investor type

Mutual Fund78.43%
Hedge Fund23.72%
Public Company8.64%
Individual/Insider2.21%
Government Pension Fund1.60%
Private Company0.69%
Bank/Investment Bank0.30%
Family Office/Trust0.27%

Reported short interest has risen from 16.74% to 18.97% of float over the last 6 biweekly reports (30 Jun 2026 to 15 Sep 2026).

Recent institutional activity

Holder	Type	Period	Share change	New stake
Nuveen Asset Management LLC	Insurance Company	2026/Q3	+86,236	0.2%
UBS Asset Management	Mutual Fund	2026/Q3	+349,627	2.5%
Cobas Asset Management, SGIIC, SA	Mutual Fund	2026/Q3	+303,400	0.8%
Two Sigma Investments, LP	Hedge Fund	2026/Q3	+197,753	1.8%
American Century Investment Management	Mutual Fund	2026/Q3	+180,530	2.6%
Millennium Management LLC	Hedge Fund	2026/Q3	+178,132	0.6%
Jefferies Financial Group Inc.	Public Company	2026/Q3	+173,800	0.9%
State Street Global Advisors	Mutual Fund	2026/Q3	+140,367	5.2%
Marshall Wace LLP	Hedge Fund	2026/Q3	+129,348	0.3%
Numeric Investors LLC	Hedge Fund	2026/Q3	+125,370	0.3%
FMR	Mutual Fund	2026/Q3	+123,467	0.5%
JPMorgan Chase & Co.	Public Company	2026/Q3	+116,611	0.7%
Assenagon Asset Management S.A.	Mutual Fund	2026/Q3	+101,429	0.3%
WEDGE Capital Management LLP	Mutual Fund	2026/Q3	+94,554	0.2%
LSV Asset Management	Mutual Fund	2026/Q3	+91,276	1.5%

Institutional buy/sell activity by reporting period, largest moves first.

Insider transactions

Date	Insider	Title	Transaction	Shares	Price	Held after
16 Aug 2026	Jonathan Slonin	Chief Clinical Officer	Automatic Disposition	-3,040	$23.23	61,988
11 Jun 2026	Abraham Ceesay	Independent Director	Intent to Sell (Form 144)	-9,039	$23.27	–
10 Jun 2026	Lauren Riker	Principal Accounting Officer & VP of Finance	Automatic Disposition	-6,115	$23.50	62,284
9 Jun 2026	Laura Brege	Independent Director	Other Acquisition	+6,405	–	12,568
9 Jun 2026	Laura Brege	Independent Director	Other Derivative Acquisition	+10,891	$23.42	10,891
9 Jun 2026	Thomas Wiggans	Independent Director	Other Derivative Acquisition	+32,675	$23.42	32,675
9 Jun 2026	Christopher Christie	Independent Director	Other Acquisition	+6,405	–	12,568
9 Jun 2026	Christopher Christie	Independent Director	Other Derivative Acquisition	+10,891	$23.42	10,891
9 Jun 2026	Alethia Young	Independent Director	Other Acquisition	+6,405	–	12,568
9 Jun 2026	Alethia Young	Independent Director	Other Derivative Acquisition	+10,891	$23.42	10,891
9 Jun 2026	Marcelo Bigal	Independent Director	Other Acquisition	+6,405	–	12,568
9 Jun 2026	Marcelo Bigal	Independent Director	Other Derivative Acquisition	+10,891	$23.42	10,891
9 Jun 2026	Mark Froimson	Independent Director	Other Acquisition	+6,405	–	12,568
9 Jun 2026	Mark Froimson	Independent Director	Other Derivative Acquisition	+10,891	$23.42	10,891
9 Jun 2026	Michael Yang	Independent Director	Other Acquisition	+6,405	–	12,568
9 Jun 2026	Michael Yang	Independent Director	Other Derivative Acquisition	+10,891	$23.42	10,891
9 Jun 2026	Samit Hirawat	Director	Other Acquisition	+6,405	–	6,405
9 Jun 2026	Samit Hirawat	Director	Other Derivative Acquisition	+10,891	$23.42	10,891
3 Jun 2026	Kristen Dunker		Automatic Disposition	-10,259	$22.27	23,229
2 Jun 2026	Kristen Dunker		Sale to Issuer	-8,528	$22.32	23,229

From Form 4/Form 144 filings. Negative share counts are disposals (sales, gifts, or shares withheld for taxes); positive are acquisitions.

Short interest, by report

Report date	Shares short	% of float	Days to cover
15 Sep 2026	7,561,153	19.0%	13.0
31 Aug 2026	7,328,377	18.4%	17.0
14 Aug 2026	7,297,363	18.3%	8.1
31 Jul 2026	7,212,032	18.3%	13.4
15 Jul 2026	6,963,375	17.7%	15.8
30 Jun 2026	6,587,848	16.7%	11.7

Discussion

No comments yet — be the first to weigh in on PCRX.